Company Valuation: MedPacto, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 2,393,411 1,201,906 469,045 243,124 152,010 228,958
Change - -49.78% -60.97% -48.17% -37.48% 50.62%
Enterprise Value (EV) 1 2,348,548 1,080,523 435,468 172,948 98,472 189,985
Change - -53.99% -59.7% -60.28% -43.06% 92.93%
P/E -94.2x -70.4x -13x -4.35x -7.42x -17.9x
PBR 43x 27.6x 14.5x 3.43x 2.63x 4.98x
PEG - 2.1x -0x 1.85x 0.1x 0.5x
Capitalization / Revenue - - - - - 58,730,052x
EV / Revenue - - - - - -
EV / EBITDA -89.1x -39x -12.3x -6.42x -4.86x -14.7x
EV / EBIT -84.5x -36.7x -11.7x -6.02x -4.52x -13.5x
EV / FCF - - - - - -
FCF Yield - - - - - -
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -1,249 -832.3 -1,705 -1,665 -598 -373.8
Distribution rate - - - - - -
Net sales - - - - - 3,898
EBITDA 1 -26,363 -27,736 -35,380 -26,919 -20,265 -12,888
EBIT 1 -27,800 -29,459 -37,246 -28,752 -21,807 -14,044
Net income 1 -25,352 -17,040 -35,753 -35,325 -20,140 -12,811
Net Debt 1 -44,863 -121,383 -33,577 -70,177 -53,538 -38,973
Reference price 2 117,700.00 58,600.00 22,250.00 7,240.00 4,435.00 6,680.00
Nbr of stocks (in thousands) 20,335 20,510 21,081 33,581 34,275 34,275
Announcement Date 3/14/22 3/14/22 3/13/23 3/20/24 3/20/25 3/18/26
1KRW in Million2KRW
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 62.12M
19.5x6.01x13.15x1.63% 52.1B
32.22x8.13x25.24x0.05% 53.83B
-42.48x13.5x-39.59x-.--% 23.48B
-18.22x4.32x-7.57x-.--% 23.13B
24.24x4.75x12.54x-.--% 19.36B
24.39x4.78x15.56x-.--% 17.56B
45.88x18.59x47.88x0.08% 15.2B
-505.73x35.47x-1462.84x-.--% 14.83B
17.57x5.11x11.88x-.--% 14.06B
Average -44.74x 11.19x -153.75x 0.2% 23.36B
Weighted average by Cap. -18.52x 9.52x -82.82x 0.38%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. A235980 Stock
  4. Valuation MedPacto, Inc.